OMER FY 2008 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$810M

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-39.2% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$25M-2096.2% margin

Net Income

-$24M-2036.5% margin

EPS (Diluted)

$-2.22

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$22M

Total Liabilities

$113M

Stockholders' Equity

-$91M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-39.2%
Gross Profit	$1M	$2M	-39.2%
Operating Income	-$25M	-$24M	-0.5%
Net Income	-$24M	-$23M	-3.2%